Today, neglected tropical diseases are a symptom of poverty and disadvantage. Those most affected are the poorest populations often living in remote, rural areas, urban slums or in conflict zones. …Although medically diverse, neglected tropical diseases share features that allow them to persist in conditions of poverty, where they cluster and frequently overlap. Over 1 billion people – one sixth of the world's population – suffer from one or more neglected tropical diseases. Conflict situations or natural disasters aggravate conditions that are conducive to the spread of these diseases (World Health Organization).
G MIST is committed to engage in research activities pertaining to discovering innovative therapeutics and diagnostic agents in specific neglected disease areas. In its state-of-the-art laboratory G MIST has specific plans for vaccine development and manufacturing against tropical diseases that affect human and animal health.
Contract Research services
G MIST has extensive network with vendors worldwide and partnership with privately and publicly funded premier institutions. Thus it makes G MIST a perfect candidate for a contract research organization (CRO).
Provides services in the life cycle of a product from its conception to commercialization
Important strategic partnerships from logistics support to decision making exercise
Product development and formulation
Clinical trial management (preclinical through phase IV)
Central laboratory services for processing trial samples
Data management services for preparation of an Investigational New Drug Application (IND)
